Intrauterine devices and pelvic inflammatory disease: Evolving perspectives on the data

Obstetrical and Gynecological Survey

Volumn 51, Issue 12 SUPPL., 1996, Pages

  Burkman, Ronald T ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FAMILY PLANNING; HUMAN; INTENSIVE CARE; INTRAUTERINE CONTRACEPTIVE DEVICE; PELVIC INFLAMMATORY DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS;

AMERICAS; BIAS; CONTRACEPTION; CONTRACEPTIVE METHODS--COMPLICATIONS; DEVELOPED COUNTRIES; DISEASES; ENGLAND; ERROR SOURCES; EUROPE; EVALUATION; FAMILY PLANNING; INCIDENCE; INFECTIONS; IUD--COMPLICATIONS; LITERATURE REVIEW; MEASUREMENT; NORTH AMERICA; NORTHERN AMERICA; NORTHERN EUROPE; PELVIC INFLAMMATORY DISEASE; REPRODUCTIVE TRACT INFECTIONS; RESEARCH METHODOLOGY; RISK ASSESSMENT; SCOTLAND; UNITED KINGDOM; UNITED STATES; WORLD;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INTRAUTERINE DEVICES; PELVIC INFLAMMATORY DISEASE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; RISK; UNITED STATES;

EID: 0030455614     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Scott RB. Critical illnesses and death associated with intrauterine devices. Obstet Gynecol 1968;31:322-328.
2. Wright NH, Laemmle P. Acute pelvic inflammatory disease in an indigent population. Am J Obstet Gynecol 1968;101:979-990.
3. Targum SD, Wright NH. Association of the intrauterine device and pelvic inflammatory disease: A retrospective pilot study. Am J Epidemiol 1974;100:262-271.
4. Noonan AS, Adams JB. Gonorrhea screening in an urban hospital family planning program. Am J Public Health 1974;64:700-704.
5. Phaosavasdi S, Vivanichakul B, Rienprayura D. Pelvic inflammatory disease in contraceptive acceptors disclosed at transvaginal tubal sterilization. In: Hefnawi F, Segal SJ, eds. Analysis of Intrauterine Contraception. Amsterdam: North Holland Publishing, 1975, pp 397-399.
6. Lippes J. Infection and the IUD: A preliminary report. Contraception 1975;12:103-106.
7. Wright NH and The Combined Bangkok Hospital Group. Unsuspected pelvic infection discovered at tubal ligation: Relationship to use of intrauterine contraception, In: Hefnawi F, Segal SJ, eds. Analysis of Intrauterine Contraception. Amsterdam: North Holland Publishing, 1975, pp 401.
8. Westrom L, Bengtsson LP, Mardh PA. The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to nonusers. Lancet 1976;2:221-224.
9. Faulkner WL, Ory HW. Intrauterine devices and acute pelvic inflammatory disease. J Am Med Assoc 1976;235:1851-1853.
10. Vessey M, Doll R, Peto R et al. Long-term follow-up study of women using different methods of contraception: An interim report. J Biosoc Sci 1976;8:373-427.
11. Eschenbach DA, Harnish JP, Holmes KK. Pathogenesis of acute pelvic inflammatory disease: Role of contraception and other risk factors. Am J Obstet Gynecol 1977;128:838-850.
12. Thaler I, Paldi E, Steiner D. Intrauterine device and pelvic inflammatory disease. Int J Fertil 1978;23:69-72.
13. Flesh G, Weiner JM, Corlett RC et al. The intrauterine contraceptive device and acute salpingitis: A multifactorial analysis. Am J Obstet Gynecol 1979;135:402-408.
14. Maqueo M, Calderon JJ, Guerra A. Salpingitis associated with the presence of non-medicated IUDs. Contraception 1979;19:539-542.
15. Ryden G, Fahraeus L, Molin L et al. Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhea. Contraception 1979;20:149-157.
16. Kaufmann DW, Shapiro S, Rosenberg L et al. Intrauterine contraceptive device use and pelvic inflammatory disease. Am J Obstet Gynecol 1980;136:159-162.
17. Osser S, Gullberg B, Liedholm P et al. Risk of pelvic inflammatory inflammatory disease among intrauterine device users irrespective of previous pregnancy. Lancet 1980;1:386-388.
18. Paavonen J, Vesterinen E. Intrauterine contraceptive device use in patients with acute salpingitis. Contraception 1980;22:107-114.
19. Rolfs RT, Galaid EI, Zaidi AA. Pelvic inflammatory disease: Trends in hospitalizations and office visits, 1979 through 1988. Am J Obstet Gynecol 1992;166:983-990.
20. Burkman RT. Intrauterine device use and the risk of pelvic inflammatory disease. Am J Obstet Gynecol 1980;138:861-863.
21. Senanayake P, Kramer DG. Contraception and the etiology of pelvic inflammatory disease: new perspectives. Am J Obstet Gynecol 1980;138:852-860.
22. Grimes DA. Intrauterine devices and pelvic inflammatory disease: Recent developments. Contraception 1987;36:97-109.
23. Chi I. What we have learned from recent IUD studies: a researcher's perspective. Contraception 1993;48:81-108.
24. Petitti DB. Reconsidering the IUD. Fam Plann Perspect 1992;24:33-35.
25. Burkman RT, and the Women's Health Study: Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol 1981;57:269-276.
26. Lee NC, Rubin GL, Ory HW et al. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1-6.
27. Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol 1988;72:1-6.
28. Mumford SD, Kessel E. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings. Fertil Steril 1992;57:1151-1176.
29. Burkman RT, Lee NC, Ory HW et al. Response to "The intrauterine device and pelvic inflammatory disease: The Women's Health Study reanalyzed." J Clin Epidemiol 1991;44:123-125.
30. Sivin I. Another look at the Dalkon Shield: Meta-analysis underscores its problems. Contraception 1993;48:1-12.
31. Vessey MP, Flavel R, McPherson K. Pelvic inflammatory disease and the intrauterine device: Findings in a large cohort study. Br Med J 1981;282:855-857.
32. Buchan H, Villard-Mackintosh L, Vessey M et al. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol 1990;97:780-788.
33. Farley TMM, Rosenberg MJ, Rowe PJ et al. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992;339:785-788.
34. Tietze C, Lewit S. Evaluation of intrauterine devices: Ninth progress report of the Cooperative Statistical Program. Stud Fam Plann 1970;55:1-40.
35. Stadel BV, Schlesselman S. Extent of pelvic surgery in relation to duration of intrauterine device use. Obstet Gynecol 1984; 63:171-177.
36. Harlap S, Kost K, Forrest JD. Preventing Pregnancy, Protecting Health: A New Look at Birth Control Choices in the United States. New York: The Alan Guttmacher Institute, 1991, pp 47.
37. Farley TMM. Incidence of infection-related problems among IUD users: Perspectives from the post-marketing surveillance of Norplant. In: Bardin CW, Mishell DR, eds. Proceedings from the Fourth International Conference on IUDs. Boston: Butterworth-Heinemann, 1994, pp 151-163.
38. Kaufman DW, Watson J, Rosenberg L et al. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease. J Am Med Assoc 1983;250:759-762.
39. Fiorino AS. Intrauterine contraceptive device-associated actinomycotic abscess and actinomyces detection on cervical smear. Obstet Gynecol 1995;87:42-49.
40. Burkman RT, Schlesselman S, McCaffrey L et al. The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease. Am J Obstet Gynecol 1982;143:585-589.
41. Gupta PK, Hollander DH, Frost JK. Actinomycetes in cervicovaginal smears: An association with IUD usage. Acta Cytol 1976;20:295-297.
42. Valincenti JF, Pappas AA, Graber CD et al. Detection and prevalence of IUD-associated Actinomyces colonization and related morbidity. J Am Med Assoc 1982;247:1149-1152.
43. Gupta PK. Intrauterine contraceptive devices: Vaginal cytology pathologic changes and clinical implications. Acta Cytol 1982;26:571-613.
44. Burkman RT, Damewood MT. Actinomyces and the intrauterine contraceptive device. In: Zatuchni GI, Goldsmith A, Sciarra JJ, eds. PARFR Series on Fertility Regulation: Intrauterine Contraception-Advances and Future Prospects. Philadelphia: Harper and Row, 1985, pp 427-437.
45. Persson E, Holmberg K, Dahlgren S et al. Actinomyces israelii in the genital tract of women with and without intrauterine contraceptive devices. Acta Obstet Gynecol Scand 1983;62:563-568.
46. Curtis EM, Pine L. Actinomyces in the vaginas of women with and without intrauterine contraceptive devices. Am Obstet Gynecol 1981;152:287-290.